Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Restructuring Costs (2016 - 2025)

Surgery Partners' Restructuring Costs history spans 12 years, with the latest figure at $18.5 million for Q4 2025.

  • For Q4 2025, Restructuring Costs fell 45.59% year-over-year to $18.5 million; the TTM value through Dec 2025 reached $73.9 million, down 26.17%, while the annual FY2025 figure was $73.9 million, 26.17% down from the prior year.
  • Restructuring Costs for Q4 2025 was $18.5 million at Surgery Partners, up from $12.6 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $34.0 million in Q4 2024 and bottomed at $5.3 million in Q1 2021.
  • The 5-year median for Restructuring Costs is $14.0 million (2021), against an average of $16.2 million.
  • The largest annual shift saw Restructuring Costs surged 129.69% in 2024 before it crashed 57.14% in 2025.
  • A 5-year view of Restructuring Costs shows it stood at $15.1 million in 2021, then surged by 30.46% to $19.7 million in 2022, then increased by 23.86% to $24.4 million in 2023, then surged by 39.34% to $34.0 million in 2024, then plummeted by 45.59% to $18.5 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Restructuring Costs are $18.5 million (Q4 2025), $12.6 million (Q3 2025), and $18.1 million (Q2 2025).